WebApr 14, 2024 · In other Ironwood Pharmaceuticals news, COO Jason Rickard sold 16,746 shares of the stock in a transaction on Monday, February 27th. The shares were sold at an average price of $11.41, for a total ... WebApr 15, 2024 · The stock, however, is off -83.80% from where it was a year ago. Additionally, there is a loss of -2.06% for Cumberland Pharmaceuticals Inc. (CPIX) in last trading while the stock has seen an overall depriciation of -26.73%% over the past year. The PE ratio stands at 11.39 for Ironwood Pharmaceuticals Inc., compared to 70.08 for AstraZeneca PLC.
Everence Capital Management Inc. Has $558,000 Stock Holdings …
WebApr 13, 2024 · ONTONAGON, Mich. — Troy Armour, of Ontonagon, passed away unexpectedly March 16, 2024. He was born Nov. 3, 1987, to Cathy and Dennis Armour. … WebJan 29, 2024 · Astellas Pharma Inc. (TSE:4503) and Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) announced today top-line results indicating that the Phase III clinical trial of linaclotide conducted in Japan in adults with chronic constipation (CC) met its primary endpoint. Linaclotide is approved in Japan as the first prescription treatment for adults … ray\\u0027s pool and spa facebook
Will Ironwood Pharmaceuticals, Inc. (IRWD) Stay at the Bottom of …
WebIronwood Pharmaceuticals 27,221 followers 1d Edited Our Director of Research Quality Assurance, Cheryl McCarthy, CQA, CBA, RQAP-GCP will be giving the President’s speech as well as chairing the... WebApr 14, 2024 · Ironwood Pharmaceuticals Stock Performance IRWD opened at $11.10 on Friday. The stock has a market capitalization of $1.71 billion, a PE ratio of 11.44 and a beta of 0.95. Ironwood Pharmaceuticals, Inc. has a one year low … WebIronwood Pharmaceuticals’ commitment to redefining the standard of care for patients suffering from GI diseases and disorders is unwavering. We understand that debilitating GI diseases exist, and countless patients need meaningful and effective medicines. ray\\u0027s portsmouth ri